IDH2 and oligodendroglioma: Notably, in patients with grade 2 oligodendroglioma harboring IDH mutation, 1p/19q co-deletion, and CIC mutation, the administration of PCV chemotherapy following radiotherapy has demonstrated significant survival benefits [7].